Comtech Telecommunications Corp. heads into the final day of April nursing a sharp weekly loss, with the stock down 14% to $3.50 — and the market still digesting a brutal earnings reaction from mid-March.
The earnings history is the sharpest item in this story. When Comtech reported in March, the stock fell 21.6% in a single session and extended that to a 22% loss over five days. That print left a visible scar on the chart. The month of April has partially healed the wound — the stock recovered 12.9% from its post-print low — but Wednesday's 0.6% slide and the broader weekly drop suggest the recovery has stalled. The next earnings event is scheduled for June 12, giving traders roughly six weeks before the next binary moment.
The positioning data is notably calm given what the price has done. Short interest runs at just 2.1% of the free float, down 16% over the past month as shorts have been reducing their exposure since the March earnings drop. Borrow costs are low — 0.56% annualised — and ticked up 27% over the past week, though from a very cheap base. Availability remains ample, well above normal levels, meaning the lending market is not placing any meaningful squeeze pressure on the stock. The ORTEX short score of 33 sits in the bottom half of the universe, consistent with a stock that bears do not view as a high-conviction target. If anything, the steady short-covering through April tells a more optimistic story than the price action would suggest.
Options positioning reinforces the lack of aggressive directional conviction. The put/call ratio of 0.29 is fractionally below its 20-day average of 0.30, producing a z-score close to zero. That is notable context: after a 22% earnings-day crash, options traders are not rushing to buy protection. The PCR did spike to 0.55–0.81 in the days immediately following the March print, but it has since normalised. The 52-week high on the PCR is 1.40, so the current reading is at the calmer end of the range — demand for downside hedges has faded even as the price has struggled this week.
The analyst picture is stale and should be read with caution. The most recent formal coverage action was B. Riley's Mike Crawford lowering his target to $6.00 in June 2025, nine months ago — well past any relevance to today's $3.50 price. At that time the rating remained Buy. With the stock now trading materially below every historical target on record, the Street coverage has effectively gone dark on this name. The EV/EBITDA multiple has contracted sharply, down more than 5.5 points over 30 days to 13.1x, and the price/book has compressed to 0.84x — both reflecting the post-earnings re-rating. The EPS surprise factor score ranks in the 94th percentile, an irony given the March outcome, suggesting the miss caught most models off guard.
On the institutional side, QVT Financial added roughly 408,000 shares as of December 2025, making it the second-largest holder at 4.7%. Marshall Wace also built a new position of 352,000 shares over the same period. Neither move can be read as a recent endorsement of the price — both predate the March earnings collapse — but they do indicate that event-driven money was accumulating before the reset. Royce & Associates remains the largest named holder at 5.5%.
The question heading into June 12 is whether the cost discipline in the Terrestrial & Wireless Networks segment — which grew strongly in the last reported quarter — can offset continued weakness in the Satellite segment, where the book-to-bill ratio was running at a deeply concerning 0.26x. With analyst coverage effectively dormant and the stock trading under $4, the June print carries disproportionate weight for an otherwise lightly-followed name.
See the live data behind this article on ORTEX.
Open CMTL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
